Last viewed: PLX


Prices are updated after-hours



amex:PLX Protalix BioTherapeutics, Inc.

PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services

(0.0% 1d) (0.0% 1m) (-15.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (47.02% volume)
Earnings Calendar:
Market Cap: $ 52,241,079

http://www.protalix.com
Sec Filling | Patents | 196 employees


(IL) Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.

israel   t-cell   ceiling  

add to watch list email alert is off

Press-releases


Protalix BioTherapeutics to Present in Person at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-12 (Crawled : 17:00) - prnewswire.com
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 0.47% H: 2.8% C: -0.93%

global conference
Protalix BioTherapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 11:00) - biospace.com/
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist

global conference
Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
Published: 2022-08-15 (Crawled : 12:00) - biospace.com/
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: -0.41% H: 2.48% C: 2.48%

results
Protalix BioTherapeutics to Announce Second Quarter 2022 Financial and Business Results Conference Call on August 15, 2022
Published: 2022-08-08 (Crawled : 12:00) - prnewswire.com
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 0.91% H: 0.0% C: 0.0%

conference results
Protalix BioTherapeutics Appoints Shmuel "Muli" Ben Zvi, Ph.D. to its Board of Directors
Published: 2022-06-30 (Crawled : 21:00) - prnewswire.com
VBLT | $0.1694 5.74% 0.67% | twitter stocktwits trandingview |
Health Technology
| | O: 0.24% H: 1.62% C: 1.0%
SLGL | $5.17 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 10.85% C: 6.67%
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: -0.93% H: 0.94% C: 0.47%


Protalix BioTherapeutics Announces Poster Presentations at the 2022 Program: 7th Update on Fabry Disease
Published: 2022-05-26 (Crawled : 21:00) - prnewswire.com
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 0.0% H: 4.55% C: 3.64%

disease
Protalix BioTherapeutics Reports First Quarter 2022 Financial and Business Results
Published: 2022-05-16 (Crawled : 11:00) - prnewswire.com
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 2.94% H: 8.57% C: 1.9%

results
Protalix BioTherapeutics to Announce First Quarter 2022 Financial and Business Results Conference Call on May 16, 2022
Published: 2022-05-09 (Crawled : 12:00) - biospace.com/
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 2.73% H: 0.0% C: -7.08%

conference results
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Topline Results from the 24-Month Phase III BALANCE Clinical Trial of PRX-102 for the Treatment of Fabry Disease
Published: 2022-04-04 (Crawled : 11:00) - prnewswire.com
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 43.81% H: 32.45% C: -1.32%

prx-102 treatment rare disease topline trial results
Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results
Published: 2022-03-31 (Crawled : 12:00) - biospace.com/
PLX | $1.05 2.86% | twitter stocktwits trandingview |
Health Services
| | O: 0.0% H: 8.57% C: 0.95%

results
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001104659-22-098956 4 2022-09-09 2022-09-07 Buy A 10000 10000
0001104659-22-098953 4 2022-09-09 2022-09-07 Buy A 340000 340000
0001104659-22-098951 4 2022-09-09 2022-09-07 Buy A 250000 250000
0001104659-22-098950 4 2022-09-09 2022-09-07 Buy A 350000 350000
0001104659-22-098949 4 2022-09-09 2022-09-07 Buy A 750000 750000


Your Today's Watch List
Sign in to create a watchlist
Top 10 Gainers
LEJU | $1.63 -7.91% 15.95% | twitter stocktwits trandingview |
Finance

DPSI | $6.62 13.55% 11.78% | twitter stocktwits trandingview |
Information

PHGE | $0.36 14.29% 8.31% | twitter stocktwits trandingview |
Health Technology

ITRG | $0.5599 1.73% 6.89% | twitter stocktwits trandingview |
Non-Energy Minerals

SEB | $3466.02 -0.53% 6.55% | twitter stocktwits trandingview |
Consumer Non-Durables

AGE 4 | $0.5495 -5.14% 6.28% | twitter stocktwits trandingview |
Health Technology

RHE | $2.58 11.21% 6.2% | twitter stocktwits trandingview |
Finance

BDN | $7.16 4.22% 6.15% | twitter stocktwits trandingview |
Finance

BKD | $4.24 -4.72% 5.9% | twitter stocktwits trandingview |
Health Services

CIG.C | $3.41 -7.59% 5.87% | twitter stocktwits trandingview |
n/a


Last 48 Hours Insiders Buying
UTG P 400 | $34.13 0% | twitter stocktwits trandingview |
Miscellaneous
| 18:00

12 months watchlist earnings calendar